Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Bill Wexler's Profits of DOOM -- Ignore unavailable to you. Want to Upgrade?

To: Bradpalm1 who wrote (427)	3/16/1998 5:06:00 PM
From: Bill Wexler	Respond to of 4634

Pfizer continues its success. Zonagen continues its fraud. Today Pfizer stock was up on anticipation of approval for Viagra...a legitimate treatment for male erectile dysfunction. biz.yahoo.com Zonagen is a criminal enterprise that has succeeded in defrauding small investors out of millions of dollars by claiming that it too has a treatment for ED. The drug is called Vasomax. Vasomax has only one active ingredient, Phentolamine, which is completely ineffective for ED. Zonagen has committed similar frauds in the past and is now the subject of at least three lawsuits. Zonagen's stock has been artificially propped up through the combination of clever stock promotion and the naive hope of certain investors that Vasomax can somehow capture a small portion of Viagra's market. This scenario is laughable and impossible. Vasomax simply does not work and will not receive FDA approval. Furthermore; Zonagen does not posses the infrastructure necessary to bring ANY drug to market. Zonagen will soon trade in the low single digits.